SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 7 filers reported holding SILENCE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,675,000 | +52.0% | 700,000 | 0.0% | 0.03% | +52.9% |
| Q3 2022 | $7,025,000 | +4.9% | 700,000 | +23.9% | 0.02% | +13.3% |
| Q2 2022 | $6,695,000 | -35.9% | 565,000 | +2.7% | 0.02% | -25.0% |
| Q1 2022 | $10,450,000 | -20.5% | 550,000 | 0.0% | 0.02% | -16.7% |
| Q4 2021 | $13,140,000 | +43.4% | 550,000 | +23.8% | 0.02% | +33.3% |
| Q3 2021 | $9,160,000 | -21.2% | 444,444 | 0.0% | 0.02% | -21.7% |
| Q2 2021 | $11,629,000 | +13.8% | 444,444 | 0.0% | 0.02% | +9.5% |
| Q1 2021 | $10,222,000 | – | 444,444 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,284,133 | $19,583,028 | 7.36% |
| TCG Crossover Management, LLC | 2,104,875 | $32,099,344 | 5.66% |
| M28 Capital Management LP | 145,900 | $2,224,975 | 2.12% |
| Lombard Odier Asset Management (Europe) Ltd | 3,218,200 | $49,077,550 | 1.99% |
| Lombard Odier Asset Management (USA) Corp | 3,875,734 | $50,594,057 | 1.29% |
| Deep Track Capital, LP | 1,951,580 | $29,761,595 | 1.25% |
| BVF INC/IL | 1,508,416 | $23,003,344 | 0.97% |
| Frazier Life Sciences Management, L.P. | 881,173 | $13,437,888 | 0.84% |
| Parkman Healthcare Partners LLC | 134,842 | $2,056,341 | 0.55% |
| CANTOR FITZGERALD, L. P. | 301,690 | $4,601 | 0.10% |